Equity Overview
Price & Market Data
Price: $0.759
Daily Change: $0.00 / 0.00%
Range: $0.759 - $0.759
Market Cap: $524,349,856
Volume: 905
Performance Metrics
1 Week: 6.61%
1 Month: -8.66%
3 Months: -46.11%
6 Months: -48.04%
1 Year: -46.11%
YTD: -37.82%
Company Details
Employees: 254
Sector: Health technology
Industry: Biotechnology
Country: Australia
Details
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.